Arrowhead Pharmaceuticals, Inc. (ARWR)

Last Closing Price: 16.82 (2025-05-29)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Arrowhead Pharmaceuticals, Inc. (ARWR) had Net Income of $370.44M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$542.71M
Net Income
$370.44M
--
$542.71M
$161.51M
$381.20M
$-11.59M
$369.62M
$369.62M
$367.86M
$367.86M
$367.86M
$367.86M
$381.20M
$390.20M
133.36M
134.48M
$2.78
$2.75
Balance Sheet Financials
$1.14B
$384.80M
$438.28M
$1.57B
$220.54M
$208.93M
$668.73M
$889.27M
$684.23M
$676.51M
$684.23M
138.06M
Cash Flow Statement Financials
$313.78M
$-343.30M
$113.02M
$102.69M
$185.71M
$83.02M
$31.24M
--
--
Fundamental Metrics & Ratios
5.15
--
--
0.23
0.40
100.00%
70.24%
70.24%
--
68.11%
68.26%
$300.97M
--
--
--
0.34
--
229.48
0.39
53.76%
54.38%
23.38%
41.19%
$4.96
$2.24
$2.33